Shares of health insurance company Humana (NYSE:HUM) fell 20.6% in the afternoon session after the Centers for Medicare & ...

A federal proposal targeting Medicare Advantage payments sent Louisville-based Humana’s stock down about 20% Tuesday and ...

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...

45+ Medicare companies and brands analyzed by our team of experts. 30+ years of combined experience covering Medicare and personal finance. Governed by NerdWallet's strict guidelines for editorial ...

Humana has lost a second lawsuit aiming to challenge the star ratings in Medicare Advantage (MA). The insurer, which has the bulk of its insurance business in MA, initially lost a legal fight ...

The healthcare sector, led by insurance stocks, has faced chronic underperformance since 2020 as premiums fail to keep up with costs. Humana has faced significant pressures, losing over 30% of its ...

Humana is one of the many Medicare-approved private insurance companies that offer Medicare Advantage (Part C) plans. These plans are an alternative to Original Medicare (Part A and Part B) plans.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025.

Thousands of patients insured through Humana's Medicare Advantage plans are no longer "in network" at Aultman hospitals. Adam Luntz, senior vice president of finance at Aultman, said the contract ...